BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1384634)

  • 1. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on cytotoxicity of PSK-induced peritoneal polymorphonuclear leukocytes (PMNs).
    Kato H; Inoue M; Yamamura Y; Kawahito Y; Mukai S; Sugino S; Kondo M
    Biotherapy; 1992; 5(3):177-86. PubMed ID: 1384634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human granulocyte colony-stimulating factor augments cytotoxicity of OK-432-induced polymorphonuclear leukocytes.
    Inoue M; Kato H; Mukai S; Kawahito Y; Asai K; Kimura S; Yamamura Y; Sano H; Sugino S; Kondo M
    Int J Immunopharmacol; 1994 Jan; 16(1):19-28. PubMed ID: 7512080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro augmentation of cytotoxicity by N-CWS in peritoneal polymorphonuclear leukocytes (PMNs) induced by PSK, OK-432 or N-CWS.
    Kato H; Yamamura Y; Inoue M; Tanigawa M; Kimura S; Sugino S; Kondo M
    Biotherapy; 1992; 4(1):69-73. PubMed ID: 1543653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological study of cytotoxicity produced by PSK-induced polymorphonuclear leukocytes (PMNs) and Nocardia rubra cell wall skeleton.
    Kata H; Inoue M; Mukai S; Kawahito Y; Yoshida T; Asai K; Kimura S; Hashiramoto A; Yamamura Y; Sano H; Sugino S; Kondo M
    Biotherapy; 1996; 9(4):229-39. PubMed ID: 9012542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSK and OK-432-induced immunomodulation of inducible nitric oxide (NO) synthase gene expression in mouse peritoneal polymorphonuclear leukocytes and NO-mediated cytotoxicity.
    Asai K; Kato H; Hirose K; Akaogi K; Kimura S; Mukai S; Inoue M; Yamamura Y; Sano H; Sugino S; Yoshikawa T; Kondo M
    Immunopharmacol Immunotoxicol; 2000 May; 22(2):221-35. PubMed ID: 10952028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor does not enhance phagocytosis or microbicidal activity of human mature polymorphonuclear neutrophils in vitro.
    Shimono N; Okada K; Takeda D; Eguchi K; Misumi H; Sawae Y; Niho Y
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):556-62. PubMed ID: 8556501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
    Kuni-Eda Y; Okabe M; Kurosawa M; Maekawa I; Higuchi M; Kawamura M; Morioka M; Suzuki S; Ohmura T; Fujimoto N
    Leuk Lymphoma; 1995 Feb; 16(5-6):471-6. PubMed ID: 7540462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.
    Rotondaro L; De Paolis E; Ferrero D; D'Alatri L; Raucci G; Fabbri A; Gerwig GJ; Kamerling JP; Mariani MF; Mele A; De Santis R
    Mol Biotechnol; 1999 Apr; 11(2):117-28. PubMed ID: 10464766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
    Sugiura M; Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1997 Jun; 20(6):684-9. PubMed ID: 9212991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
    Matsuzaki G; Li XY; Ohyama Y; Nomoto K
    Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance.
    Hamood M; Bluche PF; De Vroey C; Corazza F; Bujan W; Fondu P
    Mycoses; 1994; 37(3-4):93-9. PubMed ID: 7531290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.
    Repp R; Valerius T; Sendler A; Gramatzki M; Iro H; Kalden JR; Platzer E
    Blood; 1991 Aug; 78(4):885-9. PubMed ID: 1714327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of chemotherapeutic effects by recombinant human granulocyte colony-stimulating factor on implanted mouse bladder cancer cells (MBT-2).
    Akaza H; Fukushima H; Koiso K; Aso Y
    Cancer; 1992 Feb; 69(4):997-1002. PubMed ID: 1370920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor.
    Ericson SG; Zhao Y; Gao H; Miller KL; Gibson LF; Lynch JP; Landreth KS
    Blood; 1998 Mar; 91(6):2099-107. PubMed ID: 9490696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte kinetics in neutrophilia induced by recombinant human granulocyte colony-stimulating factor in mice.
    Yamagiwa A
    Fukushima J Med Sci; 1991 Jun; 37(1):1-11. PubMed ID: 1725671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.